Initial steps include analytical validation of a serum assay panel (p-cresol, S1P, 7-HOCA, DLST, MSR1, PGAM2, and ATG5) as well as known hallmarks of cancer proteins with standardized pre-analytics and central IDH and MGMT testing. The gene discussed is PGAM2; the disease is cancer.